APOE and dementia: In contrast, among Black participants, APOE-ε2 carriers at social advantage did not present a lower risk of dementia, and APOE-ε4 carriers at social advantage showed no difference in dementia risk compared to APOE-ε3ε3 carriers at social advantage (S10.b Table in S1 File).